664MO Long-term efficacy and safety of larotrectinib in TRK fusion primary central nervous system tumours: An updated analysis.
Saved in:
| Title: | 664MO Long-term efficacy and safety of larotrectinib in TRK fusion primary central nervous system tumours: An updated analysis. |
|---|---|
| Authors: | Valero-Arrese, L.1 (AUTHOR), Doz, F.2 (AUTHOR), Nysom, K.3 (AUTHOR), Sjöberg Bexelius, T.4 (AUTHOR), Idbaih, A.5 (AUTHOR), Geoerger, B.6 (AUTHOR), Kebudi, R.7 (AUTHOR), Burcoveanu, D-I.8 (AUTHOR), Neu, N.9 (AUTHOR), Brega, N.10 (AUTHOR), Drilon, A.11 (AUTHOR), Laetsch, T.W.12 (AUTHOR), van Tilburg, C.13 (AUTHOR), Perreault, S.14 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS484-S485. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1239 |
